IL6 and hepatocellular carcinoma: The ability of IL-6 to trigger an EMT and enhance cancer cell motility has been extended to colorectal cancer, cancer stem cells in blood vessels in head and neck squamous cell carcinomas, hepatocellular cancer, and laryngeal squamous cell carcinoma [51,52,53,54].